Skip to content

SKYSTAR BIO-PHARMACEUTICAL CO: filings

Every SKYSTAR BIO-PHARMACEUTICAL CO annual and quarterly report in the SEC record with the published financial measures it tagged, 14 filings, each linked to its SEC index.

Filing record ends 2014-11-14

The latest filing in this captured record is a 10-Q filed 2014-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. SKYSTAR BIO-PHARMACEUTICAL CO may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2014-11-14fiscal Q3 2014411140001144204-14-068847
10-Q2014-08-14fiscal Q2 2014401130001144204-14-050369
10-Q2014-05-15fiscal Q1 201439790001144204-14-031279
10-K2014-03-31fiscal FY 201341830001144204-14-019508
10-Q2013-11-14fiscal Q3 2013421160001144204-13-061871
10-Q2013-08-14fiscal Q2 2013401130001144204-13-045763
10-Q2013-05-15fiscal Q1 201340810001144204-13-029469
10-K2013-04-01fiscal FY 201240850001144204-13-019139
10-Q2012-11-14fiscal Q3 2012421240001144204-12-062612
10-Q/A2012-09-13fiscal Q2 2012401160001144204-12-051121
10-Q2012-05-15fiscal Q1 201235740001144204-12-029585
10-K2012-03-30fiscal FY 201135720001144204-12-019033
10-Q2011-11-14fiscal Q3 2011351030001144204-11-064668
10-Q/A2011-09-21fiscal Q2 201134980001144204-11-054104

Inspect the source

Entity
SKYSTAR BIO-PHARMACEUTICAL CO / CIK 0001076939
Captured
SEC response SHA-256
d8a65cf54c4bf27fa61797f1bd20f2af91d87c7c6e9bd44fc78d05c68ff517d1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001076939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))